# A Study of LY2484595 on Pharmacokinetics in Healthy Participants

> **NCT01448824** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 82 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** LY2484595
- **DRUG:** Placebo
- **DRUG:** Ketoconazole

## Key facts

- **NCT ID:** NCT01448824
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01448824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01448824, "A Study of LY2484595 on Pharmacokinetics in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01448824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*